WELLS FARGO & COMPANY/MN - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 64 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2023$2,912
+171.6%
1,941
+188.0%
0.00%
Q2 2023$1,072
+133.0%
674
+5.1%
0.00%
Q1 2023$460
+25.7%
641
+1.4%
0.00%
Q4 2022$366
-63.4%
632
+3.6%
0.00%
Q3 2022$1,0000.0%610
-19.0%
0.00%
Q2 2022$1,000
-90.9%
753
-91.6%
0.00%
Q1 2022$11,000
-84.1%
8,994
-77.1%
0.00%
Q4 2021$69,00039,361
+71465.5%
0.00%
Q3 2021$0
-100.0%
55
-82.0%
0.00%
Q2 2021$1,000
-99.2%
305
-97.6%
0.00%
Q1 2021$126,000
-85.1%
12,728
-83.7%
0.00%
Q4 2020$848,000
+81.6%
78,149
+72.8%
0.00%
Q3 2020$467,000
-54.2%
45,215
-7.5%
0.00%
Q2 2020$1,020,000
+197.4%
48,860
+39.4%
0.00%
Q1 2020$343,000
-86.1%
35,048
-83.7%
0.00%
-100.0%
Q4 2019$2,472,000
+1548.0%
214,549
+679.7%
0.00%
Q3 2019$150,000
-53.4%
27,518
+1.8%
0.00%
Q2 2019$322,000
+105.1%
27,041
-9.8%
0.00%
Q1 2019$157,000
+72.5%
29,973
+3.5%
0.00%
Q4 2018$91,000
-55.8%
28,950
-15.2%
0.00%
Q3 2018$206,000
+207.5%
34,142
+169.5%
0.00%
Q2 2018$67,000
+91.4%
12,668
+111.1%
0.00%
Q1 2018$35,000
+3400.0%
6,000
+2900.0%
0.00%
Q2 2017$1,000
-97.4%
200
-98.6%
0.00%
Q1 2017$39,000
-76.1%
14,447
-74.3%
0.00%
Q4 2016$163,000
+176.3%
56,151
+288.7%
0.00%
Q3 2016$59,000
+28.3%
14,4470.0%0.00%
Q2 2016$46,00014,4470.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q3 2023
NameSharesValueWeighting ↓
BML Capital Management, LLC 3,915,000$5,872,5005.39%
Versant Venture Management, LLC 5,068,233$7,602,3504.04%
Sonic GP LLC 2,000,000$3,000,0002.91%
COMMODORE CAPITAL LP 10,000,000$15,000,0001.75%
VR Adviser, LLC 6,573,300$9,859,9501.04%
AIGH Capital Management LLC 1,323,985$1,985,9770.94%
Newtyn Management, LLC 1,025,000$1,537,5000.38%
Worth Venture Partners, LLC 331,668$497,5020.30%
Acuitas Investments, LLC 291,169$436,7540.26%
Quinn Opportunity Partners LLC 398,298$597,4470.08%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders